Sucampo Pharmaceuticals, Inc.·4

May 4, 4:49 PM ET

Miele Stanley G 4

4 · Sucampo Pharmaceuticals, Inc. · Filed May 4, 2011

Insider Transaction Report

Form 4
Period: 2011-05-02
Miele Stanley G
SVP Sales & Marketing
Transactions
  • Award

    Employee Stock Option (Right to buy)

    2011-05-02+24,00024,000 total
    Exercise: $4.41Exp: 2021-05-02Class A common stock (24,000 underlying)
  • Award

    Employee Stock Option (Right to buy)

    2011-05-02+125,000125,000 total
    Exercise: $4.41Exp: 2021-05-02Class A common stock (125,000 underlying)
Footnotes (2)
  • [F1]Commencing on May 2, 2012, the first anniversary of the original grant date, the option vests annually with respect to 25% of the aggregate option share total.
  • [F2]Performance Conditions for vesting: 40% when the Fair Market Value of a share of Common Stock determined over any 30 consecutive trading days equals or exceeds $8/sh = 50,000; 40% when the Fair Market Value of a share of Common Stock determined over any 30 consecutive trading days equals or exceeds $12/sh = 50,000; and 20% when the Fair Market Value of a share of Common Stock determined over any 30 consecutive trading days equals or exceeds $16/sh = 25,000.

Documents

1 file
  • 4
    form440812_050411164923-.xmlPrimary